No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
XBI250117P87500
- 1.63
- +0.81+98.78%
15min DelayClose Jan 14 16:00 ET
1.63High0.80Low
0.80Open0.82Pre Close24 Volume183 Open Interest87.50Strike Price3.10KTurnover34.38%IV0.91%PremiumJan 17, 2025Expiry Date0.84Intrinsic Value100Multiplier2DDays to Expiry0.79Extrinsic Value100Contract SizeAmericanOptions Type-0.6240Delta0.1543Gamma59.77Leverage Ratio-0.2014Theta-0.0035Rho-37.30Eff Leverage0.0272Vega
Intraday
- 5D
- Daily
News
SPDR S&P Biotech ETF Options Spot-On: On January 14th, 92,360 Contracts Were Traded, With 927.64K Open Interest
On January 14th ET, $SPDR S&P Biotech ETF(XBI.US)$ had active options trading, with a total trading volume of 92,360 options for the day, of which put options accounted for 69.71% of the total
On the first day of the JPM Medical Conference, pharmaceutical giants are announcing new strategies. Could the mergers and acquisitions in Biomedical begin in 2025?
In 2025, the Biomedical mergers and acquisitions will begin.
SPDR S&P Biotech ETF Options Spot-On: On January 13th, 93,959 Contracts Were Traded, With 948.11K Open Interest
On January 13th ET, $SPDR S&P Biotech ETF(XBI.US)$ had active options trading, with a total trading volume of 93,959 options for the day, of which put options accounted for 61.69% of the total
SPDR S&P Biotech ETF Options Spot-On: On January 10th, 145.75K Contracts Were Traded, With 889.49K Open Interest
On January 10th ET, $SPDR S&P Biotech ETF(XBI.US)$ had active options trading, with a total trading volume of 145.75K options for the day, of which put options accounted for 61.16% of the total
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
Viking Therapeutics Among Potential Buyout Candidates: Oppenheimer